Last reviewed · How we verify
dexamethasone combined with ondansetron
At a glance
| Generic name | dexamethasone combined with ondansetron |
|---|---|
| Sponsor | AIPING ZHOU |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults (NA)
- Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer (PHASE3)
- Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting (PHASE2)
- Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy (NA)
- Ondansetron vs. Dexamethasone for Postoperative Nausea (PHASE4)
- Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery (PHASE2)
- Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer (PHASE3)
- Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dexamethasone combined with ondansetron CI brief — competitive landscape report
- dexamethasone combined with ondansetron updates RSS · CI watch RSS
- AIPING ZHOU portfolio CI